current clinical trials for Depression and Panic Disorder
Currently Recruiting
The Elumina Study
About the Study
Modern research has shown that psychedelic medicines may help treat mental health conditions – including Major Depressive Disorder (MDD). Some people with MDD do not notice an improvement in their symptoms after trying at least two of the antidepressant medications available today – this is known as Treatment-Resistant Depression (TDR).
The Elumina study is researching an investigational medicine that may offer a short-term treatment plan to improve depression symptoms.
This study is enrolling adults aged 18 to 65 who:
- Are diagnosed with MDD and are currently experiencing a depressive episode
- Have tried 2 to 5 antidepressant medications for their current depressive episode
- Do not have a diagnosis of PTSD, OCD, or a psychotic disorder such as schizophrenia
- There are other requirements which the study team will discuss with you.
The EMBRACE Trial
About the Study
The EMBRACE trial is exploring a different kind of investigational study drug to learn how effective it might be at reducing
symptoms of MDD. The investigational study drug will be combined with several psychological support sessions with a licensed therapist who has training in EMBARK, a psychological support model for MDD. You would also continue taking your current antidepressant drug. It is hoped that the investigational study drug given with psychological support may help people reach deeper into their thoughts to promote healing and potentially treat MDD.
Who can take part?
We are enrolling people aged 18 to 85 who:
- Have been diagnosed with MDD and don’t feel their current medication is treating their depression well enough
- Have been taking a single antidepressant drug at a consistent dose for at least 4 weeks
- Do not have any psychotic disorder, such as schizophrenia or bipolar disorder
- There are other requirements to join this study.
Study commitments:
- About 4 1/2 months
- 8 clinic appointments
- 8 video call appointments
- 9 psychological support sessions by video call or at the clinic
Panic Disorder - HB-PD-002 Study
What is Panic Disorder?
Do you sometimes have sudden attacks of anxiety or overwhelming fear that last for several minutes? Maybe your heart pounds, you sweat, and you feel like you cannot breathe or think clearly. Do these attacks occur at unpredictable times with no apparent trigger, causing you to worry about having another one at any time?
If so, you may have panic disorder, a common but often undiagnosed condition. And while there are several treatments available, doctors and researchers continue to study new ways to possible better treat panic disorder in the future.
About the Study
Right now, Doctors at select centres in Australia are conducting a new clinical study for adults (ages 18 to 65) who struggle with panic disorder. That study is evaluating an investigational oral medication to see if it can reduce symptoms and improve quality of life.
The study lasts about 14 weeks and involves up to 6 visits to your local study centre. These visits are an important part of the study as they allow your study doctor and staff to closely monitor your progress and results.
There is no cost to participate in the study, and you will revive all study-related care free of charge. You will be reimbursed for your travel to attend any required visits to you local study centre.
Interested to participate in a clinical trial?
Please contact the Research Team with your preferred method.
Neurocentrix Head Office
- Suite 3 Level 1, 19-21 Argyle Place South, Carlton 3053
- research@neurocentrix.com.au
- 03 9546 0009
- 03 9959 8375
Request an appointment or send an enquiry
Fields marked with * (asterisk) are required.
By entering your contact details, you agree to receive information from NeuroCentrix in the future that we believe may be relevant to you. Naturally, you can unsubscribe any time.